User:Anton Krotov/sandbox

Alex Zhavoronkov is a scientist working in biotechnology, regenerative medicine, and aging economics. He is the founder of Insilico Medicine, the director of the Biogerontology Research Foundation, a UK-based think-tank for aging research, and also the director of the International Aging Research Portfolio, an open-access repository of biomedical grants. He is the adjunct professor at the Moscow Institute of Physics and Technology.

Education
Zhavoronkov earned two bachelor's degrees at Queen's University in computer science and commerce. He has a master's in biotechnology from Johns Hopkins University and a PhD in physics and mathematics from Moscow State University.

Career
He is the co-founder and CEO of Insilico Medicine, a deep learning company focused on drug discovery and biomarker development for aging and aging-associated disease located at the Emerging Technology Centers of the Johns Hopkins University. In 2017 Insilico Medicine was included in the list of the top 5 AI startups for social impact by Nvidia at Nvidia’s GPU Technology Conference.

Publications
Since 2011, Dr. Zhavoronkov authored and co-authored over 100 scientific articles with over 85 papers referenced in PubMed. Many of the highest-impact research papers focus on the applications of deep learning techniques to drug discovery, biomarker development and aging research. He has contributed articles on trends in aging and longevity for the popular press including Huffington Post, Financial Times Pensions Expert, Next Avenue, and New Scientist.

Books

 * Featured in mainstream and business media including coverage in the Critic section of Bloomberg Businessweek, on CBS and online radio stations, and translated into both Japanese and Polish by independent publishers.
 * Featured in mainstream and business media including coverage in the Critic section of Bloomberg Businessweek, on CBS and online radio stations, and translated into both Japanese and Polish by independent publishers.